Presence of C-type natriuretic peptide (CNP) in guinea pig caecum: Role and mechanisms of CNP in circular smooth muscle relaxation

Neurogastroenterology and Motility

Volumn 16, Issue 3, 2004, Pages 375-382

  Itaba, S ^a,c   Chijiiwa, Y ^a   Matsuzaka, H ^a   Motomura, Y ^a   Nawata, H ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

Cyclic guanosine monophosphate; Natriuretic peptide receptor B; Natriuretic peptide receptor C; Smooth muscle relaxation

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; ENZYME INHIBITOR; GUANOSINE PHOSPHATE; GUANYLATE CYCLASE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CECUM; CELL CULTURE; GUINEA PIG; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; MUSCLE FIBER CONTRACTION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; SUBMUCOSA;

ANIMALS; CECUM; CELLS, CULTURED; ENZYME INHIBITORS; GUANYLATE CYCLASE; GUINEA PIGS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; NATRIURETIC PEPTIDE, C-TYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042792732     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2004.00506.x     Document Type: Article

References (43)

1. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863-70.
2. Suga S, Nakao K, Itoh H, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. J Clin Invest 1992; 90: 1145-9.
3. Minamino N, Aburaya M, Kojima M, Miyamoto K, Kangawa K, Matsuo H. Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochem Biophys Res Commun 1993; 197: 326-35.
4. Currie MG, Geller DM, Cole BR, et al. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 1983; 221: 71-3.
5. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
6. Chusho H, Tamura N, Ogawa Y, et al. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 2001; 98: 4016-21.
7. Kim JH, Jeon GH, Kim SZ, Cho KW, Kim SH. C-type natriuretic peptide system in rabbit colon. Peptides 2001; 22: 2061-8.
8. Guo HS, Jin Z, Jin ZY, et al. Comparative study in the effect of C-type natriuretic peptide on gastric motility in various animals. World J Gastroenterol 2003; 9: 547-52.
9. Maack T, Suzuki M, Almeida FA, et al. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675-8.
10. Schulz S, Singh S, Bellet RA, et al. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within new receptor family. Cell 1989; 58: 1155-62.
11. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV. Differential activation by atrial and brain natriuretic peptides of two different guanylate cyclases. Nature 1989; 341: 68-72.
12. Chinkers M, Garbers DL, Chang MS, et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989; 338: 78-83.
13. Koller KJ, Lowe DG, Bennett GL, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252: 120-3.
14. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992; 86: 1081-8.
15. Kagawa K, Suzuki S, Matsushita K, Uemura N, Morita H, Hosomi H. Relationship between the suppressive actions on intestinal absorption and on cGMP production for the natriuretic peptide family in dogs. Clin Exp Pharmacol Physiol 1994; 21: 83-92.
16. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 1984; 81: 7661-4.
17. Protter AA, Wallace AM, Ferraris VA, Weishaar RE. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 1996; 9: 432-6.
18. Akiho H, Chijiiwa Y, Okabe H, Harada N, Nawata H. Direct inhibitory effect of atrial natriuretic peptide on isolated caecal circular smooth muscle cells via soluble guanylate cyclase. Life Sci 1994; 55: 1293-9.
19. Akiho H, Chijiiwa Y, Okabe H, Harada N, Nawata H. Interaction between atrial natriuretic peptide and vasoactive intestinal peptide in guinea pig cecal smooth muscle. Gastroenterology 1995; 109: 1105-12.
20. Yasuda O, Chijiiwa Y, Motomura Y, Ochiai T, Hajime N. Interaction between brain natriuretic peptide and atrial natriuretic peptide in caecal smooth muscle cells. Regul Pept 2000; 86: 125-32.
21. Murthy KS, Teng BQ, Jin JG, Makhlouf GM. G-protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 1998; 275: C1409-16.
22. Bitar KN, Makhlouf GM. Receptors on smooth muscle cells: characterization by contraction and specific antagonists. Am J Physiol 1982; 242: G400-7.
23. Chijiiwa Y, Murthy KS, Grider JR, Makhlouf GM. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric smooth muscle cells. Regul Pept 1993; 47: 223-32.
24. Motomura Y, Chijiiwa Y, Iwakiri Y, Nawata H. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors. Life Sci 1997; 60: 499-504.
25. Sekiya M, Frohlich ED, Cole FE. The opposing effects of calmodulin, adenosine 5′-triphosphate, and pertussis toxin on phorbol ester induced inhibition of atrial natriuretic factor stimulated guanylate cyclase in SK-NEP-1 cells. Life Sci 1991; 48: 1067-73.
26. Potter LR, Hunter T. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue. A possible mechanism of heterologous desensitization. J Biol Chem 2000; 275: 31099-106.
27. Hamad AM, Knox AJ. Mechanisms involved in desensitization of particulate guanylyl cyclase in human airway smooth muscle: The role of protein kinase C. Biochem Biophys Res Commun 1999; 266: 152-5.
28. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazol o[4,3-a]quinoxalin-1-one. Mol Pharmacol 1995; 48: 184-88.
29. Rothermel JD, Botelho LH. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic) phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J 1988; 251: 757-62.
30. Kaneda T, Shimizu K, Nakajo S, Urakawa N. Effects of various selective phosphodiesterase inhibitors on muscle contractility in guinea pig ileal longitudinal smooth muscle. Jpn J Pharmacol 1997; 75: 77-85.
31. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 1992; 263: H1318-21.
32. McArdle CA, Olcese J, Schmidt C, Poch A, Kratzmeier M, Middendorff R. C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes? Endocrinology 1994; 135: 2794-801.
33. Kawai M, Naruse M, Yoshimoto T, et al. C-type natriuretic peptide as a possible local modulator of aldosterone secretion in bovine adrenal zona glomerulosa. Endocrinology 1996; 137: 42-46.
34. Suzuki E, Hirata Y, Hayakawa H, et al. Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun 1993; 192: 532-38.
35. Suda M, Tanaka K, Fukushima M, et al. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Biochem Biophys Res Commun 1996; 223: 1-6.
36. Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 1997; 35: 158-67.
37. Woodard GE, Rosado JA, Brown J. Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells. Am J Physiol 2002; 282: R156-65.
38. Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 1990; 276: 209-13.
39. Mori Y, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H. Vasodilator effects of C-type natriuretic peptide on cerebral arterioles. Eur J Pharmacol 1997; 320: 183-6.
40. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA 2003; 100: 1426-31.
41. Cooper CW, Seitz PK, McPherson MB, Selvanayagam P, Rajaraman S. Effects of parathyroid hormonal peptides on the gut. Contrib Nephrol 1991; 91: 26-31.
42. Ito M, Ohtsuru A, Enomoto H, et al. Expression of parathyroid hormone-related peptide in relation to perturbations of gastric motility in the rat. Endocrinology 1994; 134: 1936-42.
43. Suga S, Itoh H, Komatsu Y, et al. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993; 133: 3038-41.